Clinical Cancer Research Joint Metastasis Research Society-AACR Conference on Metastasis Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schimanski, C. C.
Right arrow Articles by Moehler, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schimanski, C. C.
Right arrow Articles by Moehler, M.
Clinical Cancer Research Vol. 11, 1743-1750, March 2005
© 2005 American Association for Cancer Research


Human Cancer Biology

Effect of Chemokine Receptors CXCR4 and CCR7 on the Metastatic Behavior of Human Colorectal Cancer

Carl C. Schimanski1, Stefan Schwald1, Nektaria Simiantonaki2, Caren Jayasinghe2, Ursula Gönner3, Vanessa Wilsberg1, Theodor Junginger3, Martin R. Berger4, Peter R. Galle1 and Markus Moehler1

1 First Department of Internal Medicine and Institutes of 2 Pathology and 3 Surgery, Johannes Gutenberg University of Mainz, Mainz, Germany and 4 Unit of Toxicology and Chemotherapy, German Cancer Research Centre, Heidelberg, Germany

Requests for reprints: Carl C. Schimanski, First Department of Internal Medicine, Johannes Gutenberg University of Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany. Phone: 49-6131-177276; Fax: 49-6131-177276; E-mail: dr_schimanski{at}yahoo.de.

Purpose: The expression of chemokine receptors CXCR4 and CCR7 has been associated with tumor dissemination and poor prognosis in a limited number of tumor entities. However, no data are currently available on the impact of chemokine receptor expression on disease progression and prognosis in human colorectal cancer.

Experimental Design: The expression of CXCR4 and CCR7 was evaluated in 96 patients with histologically confirmed colorectal cancers and in four colorectal cancer cell lines by immunohistochemical staining. Furthermore, cell migration assays were done with SW480, SW620, and LS174T cancer cells to confirm the effect of the CXCR4 ligand stromal cell–derived factor 1{alpha} on migration.

Results: Human colorectal cancer specimens and cell lines displayed a CXCR4 and CCR7 expression with variable intensities. Interestingly, strong expression of CXCR4, but not of CCR7, was significantly associated with higher Union International Contre Cancer stages 3/4 (P = 0.0017), lymph node metastasis (P = 0.00375), and distant metastasis (P = 0.00003) and further correlated with a reduced 3-year survival rate (P = 0.1). Strong CXCR4 and CCR7 expression positively correlated with the location of the primary tumor in the rectum (P < 0.01). Furthermore, activation of CXCR4-expressing cancer cells by stromal cell–derived factor 1{alpha} resulted in a significant increase of cell migration (P < 0.014).

Conclusion: Strong expression of CXCR4 by colorectal cancer cells is significantly associated with lymphatic and distant dissemination in patients with colorectal cancer as well as with cancer cell migration in vitro.

Key Words: lymph node metastases • liver metastases • dissemination




This article has been cited by other articles:


Home page
Cancer Res.Home page
J. Meijer, J. Ogink, B. Kreike, D. Nuyten, K. E. de Visser, and E. Roos
The Chemokine Receptor CXCR6 and Its Ligand CXCL16 Are Expressed in Carcinomas and Inhibit Proliferation
Cancer Res., June 15, 2008; 68(12): 4701 - 4708.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. K. Lau, P. C. Boutros, M. Pintilie, F. H. Blackhall, C.-Q. Zhu, D. Strumpf, M. R. Johnston, G. Darling, S. Keshavjee, T. K. Waddell, et al.
Three-Gene Prognostic Classifier for Early-Stage Non Small-Cell Lung Cancer
J. Clin. Oncol., December 10, 2007; 25(35): 5562 - 5569.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. J. Cheadle, K. Riyad, D. Subar, D. G. Rothwell, G. Ashton, H. Batha, D. J. Sherlock, R. E. Hawkins, and D. E. Gilham
Eotaxin-2 and Colorectal Cancer: A Potential Target for Immune Therapy
Clin. Cancer Res., October 1, 2007; 13(19): 5719 - 5728.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
N Cabioglu, Y Gong, R Islam, K. Broglio, N Sneige, A Sahin, A. Gonzalez-Angulo, P Morandi, C Bucana, G. Hortobagyi, et al.
Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer
Ann. Onc., June 1, 2007; 18(6): 1021 - 1029.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Hojo, K. Koizumi, K. Tsuneyama, Y. Arita, Z. Cui, K. Shinohara, T. Minami, I. Hashimoto, T. Nakayama, H. Sakurai, et al.
High-Level Expression of Chemokine CXCL16 by Tumor Cells Correlates with a Good Prognosis and Increased Tumor-Infiltrating Lymphocytes in Colorectal Cancer
Cancer Res., May 15, 2007; 67(10): 4725 - 4731.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
I. Kryczek, S. Wei, E. Keller, R. Liu, and W. Zou
Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C987 - C995.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J Kodama, Hasengaowa, T Kusumoto, N Seki, T Matsuo, Y Ojima, K Nakamura, A Hongo, and Y Hiramatsu
Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer
Ann. Onc., January 1, 2007; 18(1): 70 - 76.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Ottaiano, R. Franco, A. Aiello Talamanca, G. Liguori, F. Tatangelo, P. Delrio, G. Nasti, E. Barletta, G. Facchini, B. Daniele, et al.
Overexpression of Both CXC Chemokine Receptor 4 and Vascular Endothelial Growth Factor Proteins Predicts Early Distant Relapse in Stage II-III Colorectal Cancer Patients.
Clin. Cancer Res., May 1, 2006; 12(9): 2795 - 2803.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. Ghadjar, S. E. Coupland, I.-K. Na, M. Noutsias, A. Letsch, A. Stroux, S. Bauer, H. J. Buhr, E. Thiel, C. Scheibenbogen, et al.
Chemokine Receptor CCR6 Expression Level and Liver Metastases in Colorectal Cancer
J. Clin. Oncol., April 20, 2006; 24(12): 1910 - 1916.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. A. Bartolome, I. Molina-Ortiz, R. Samaniego, P. Sanchez-Mateos, X. R. Bustelo, and J. Teixido
Activation of Vav/Rho GTPase Signaling by CXCL12 Controls Membrane-Type Matrix Metalloproteinase-Dependent Melanoma Cell Invasion
Cancer Res., January 1, 2006; 66(1): 248 - 258.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I. Airoldi, L. Raffaghello, E. Piovan, C. Cocco, B. Carlini, A. Amadori, M. V. Corrias, and V. Pistoia
CXCL12 Does Not Attract CXCR4+ Human Metastatic Neuroblastoma Cells: Clinical Implications
Clin. Cancer Res., January 1, 2006; 12(1): 77 - 82.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2005 by the American Association for Cancer Research.